Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 276 |
Thompson Siegel & Walmsley
Richmond,
Virginia
| $42.7M | -$9.16M | 1 | 0.66% | Reduced |
|
| 277 |
C WorldWide Group
Copenhagen,
Denmark
| $42.3M | -$6.95M | 2 | 0.48% | Reduced |
|
| 278 |
MICM
Matthews International Capital Management
San Francisco,
California
| $42.2M | -$3.48M | 1 | 8.31% | Reduced |
|
| 279 |
EHI
Eagle Health Investments
Greenwich,
Connecticut
| $42.1M | +$4.23M | 3 | 7.82% | Increased |
|
| 280 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
| $41.7M | -$3.71M | 4 | 0.1% | Reduced |
|
| 281 |
MPIA
Mountain Pacific Investment Advisers
Boise,
Idaho
| $41.4M | -$7.82M | 2 | 2.32% | Reduced |
|
| 282 |
Rockefeller Capital Management
New York
| $40.9M | +$5.05M | 7 | 0.12% | Increased |
|
| 283 |
NewEdge Advisors
New Orleans,
Louisiana
| $40.6M | +$1.57M | 21 | 0.35% | Increased |
|
| 284 |
Artisan Partners
Milwaukee,
Wisconsin
| $40.6M | +$5.63M | 3 | 0.06% | Increased |
|
| 285 |
Boothbay Fund Management
New York
| $40.5M | +$6.05M | 10 | 0.78% | Increased |
|
| 286 |
MDSL
M.D. Sass LLC
New York
| $40.5M | -$7.58M | 1 | 4.57% | Reduced |
|
| 287 |
Pacer Advisors
Malvern,
Pennsylvania
| $40.3M | +$1.15M | 22 | 0.09% | Increased |
|
| 288 |
KBC Group
Brussels,
Belgium
| $40.2M | -$19.6M | 16 | 0.13% | Reduced |
|
| 289 |
NewEdge Wealth
Pittsburgh,
Pennsylvania
| $40M | +$3.55M | 3 | 0.9% | Increased |
|
| 290 |
Groupama Asset Management
Paris,
France
| $40M | +$41.5M | 3 | 0.73% | Increased |
|
| 291 |
Mizuho Markets Americas
New York
| $39.9M | -$1.48M | 2 | 0.99% | Reduced |
|
| 292 |
ACM
Argent Capital Management
St Louis,
Missouri
| $39.9M | +$20.4M | 1 | 1.16% | Increased |
|
| 293 |
Gabelli Funds
Rye,
New York
| $39.5M | +$13.3M | 3 | 0.29% | Increased |
|
| 294 |
VC
Vivo Capital
Palo Alto,
California
| $39.5M | -$73M | 4 | 3.11% | Reduced |
|
| 295 |
D1 Capital Partners
New York
| $39.3M | $0 | 1 | 0.6% | Maintained |
|
| 296 |
CCM
Cutter Capital Management
New York
| $39.2M | +$23M | 6 | 14.97% | Increased |
|
| 297 |
Oppenheimer Asset Management
New York
| $38.6M | +$1.22M | 6 | 0.57% | Increased |
|
| 298 |
TCTC Holdings
Dallas,
Texas
| $38.5M | -$50.9K | 2 | 1.28% | Reduced |
|
| 299 |
Jefferies Financial Group
New York
| $37.9M | +$3.19M | 12 | 0.35% | Increased |
|
| 300 |
SCM
Superstring Capital Management
New York
| $37.8M | +$18.9M | 5 | 25.02% | Increased |
|